Adoptive cell transfer with chimeric antigen receptor (CAR)-expressing T cells can induce remarkable complete responses in ...
Immunotherapies have shaped the cancer research space over the past decade, proving effective for the treatment of some ...
TUESDAY, Dec. 3, 2024 (HealthDay News) -- A newly approved immunotherapy can help adults with a difficult-to-treat form of ...
News Medical on MSN20h
IL-15 improves the effectiveness of GPC3 CAR T cells in targeting solid tumorsThe study reveals IL-15's role in enhancing GPC3 CAR T cell therapy, improving tumor targeting and T cell survival in ...
A novel CAR T-cell therapy has benefitted patients with relapsed acute lymphoblastic leukemia, showing high response rates in ...
Researchers report results of the first-in-human phase 1 clinical trials of a novel immunotherapy approach for solid tumors ...
T cells and allogeneic hematopoietic stem cell transplantation. Dr Simonetta's clinical work is mainly focused on Chimeric ...
News Medical on MSN13d
New CAR T-cell therapy shows promise against aggressive HER2+ breast cancerOne-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...
A new chimeric antigen receptor T cell (CAR-T) therapy has delivered promising results in treating patients with an ...
Santhosh K. Sadashiv, MD, discusses the role of chimeric antigen receptor T-cell therapy in patients with multiple myeloma.
News Medical on MSN5d
Novel CAR T cell therapy obe-cel demonstrates high response rates in adult patients with advanced B-cell ALLPatients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric antigen receptor (CAR) T cell therapy, obecabtagene ...
Preclinical studies showed that the addition of IL-15 could improve the performance of CAR T cell-based immunotherapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback